What is the recommended dosing for Trintellix (vortioxetine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trintellix (Vortioxetine) Dosing

The recommended starting dose of Trintellix is 10 mg orally once daily, which should then be increased to 20 mg daily as tolerated, with 5 mg daily reserved for patients who cannot tolerate higher doses. 1

Standard Dosing Regimen

  • Initial dose: 10 mg once daily, administered orally without regard to meals 1
  • Target dose: 20 mg once daily, as tolerated 1
  • Lower dose option: 5 mg once daily for patients who do not tolerate higher doses 1
  • Dosing frequency: Once daily administration 1
  • Food considerations: Can be taken with or without food 1

Dose Adjustments for Special Populations

CYP2D6 Poor Metabolizers

  • Maximum dose is 10 mg daily in known CYP2D6 poor metabolizers 1
  • This is the only population requiring mandatory dose adjustment based on FDA labeling 1

Drug Interactions Requiring Dose Modification

  • With strong CYP2D6 inhibitors (e.g., bupropion): Reduce Trintellix dose by half 1
  • With strong CYP inducers (e.g., rifampin): Consider increasing Trintellix dose when coadministered for more than 14 days, but do not exceed 3 times the original dose 1

Discontinuation Strategy

  • Trintellix can be discontinued abruptly without a mandatory taper 1
  • However, for doses of 15 mg or 20 mg daily: It is recommended to reduce to 10 mg daily for one week prior to full discontinuation if possible 1

Clinical Efficacy Across Dose Range

  • All three doses (5 mg, 10 mg, and 20 mg) are effective for relapse prevention in patients who achieved remission on 10 mg daily, with cumulative relapse rates of 19.3%, 17.9%, and 17.4% respectively versus 32.5% for placebo over 28 weeks 2
  • Pharmacokinetics are linear and dose-proportional across the 5-20 mg range, with steady-state achieved within 2 weeks 3
  • The mean terminal half-life is approximately 66 hours, supporting once-daily dosing 3

Important Clinical Considerations

  • No dose adjustments needed for sex, age, race, body size, or renal/hepatic impairment 3
  • Nausea is the most common side effect, typically mild to moderate and often transient 4, 5
  • Vortioxetine demonstrates procognitive effects that may be independent of its antidepressant effects 4, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.